There have been 50 recent insider transactions recorded for Scholar Rock Holding Corporation (SRRK), including 13 buys and 36 sells. Total insider buying was valued at $2.26M and total insider selling at $30.56M.
Notable insiders with recent activity include Qatanani Mo, Marantz Jing L., Ho Junlin. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — SRRK
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-02-23 |
Qatanani Mo |
Chief Scientific Officer |
Informative Sell |
200 |
$48.48 |
$9.7K |
98,445 |
| 2026-02-17 |
Marantz Jing L. |
Chief Medical Officer |
Informative Sell |
4,157 |
$46.53 |
$193.42K |
126,012 |
| 2026-02-17 |
Ho Junlin |
General Counsel |
Informative Sell |
9,580 |
$46.53 |
$445.74K |
241,545 |
| 2026-02-17 |
Parlavecchio Caryn |
Chro |
Informative Sell |
9,035 |
$46.53 |
$420.38K |
169,087 |
| 2026-02-17 |
Qatanani Mo |
Chief Scientific Officer |
Informative Sell |
7,989 |
$46.53 |
$371.71K |
106,929 |
| 2026-02-09 |
Sinha Vikas |
Chief Financial Officer |
RSU Award |
47,021 |
- |
- |
630,266 |
| 2026-02-09 |
Hallal David |
Chief Executive Officer |
RSU Award |
128,004 |
- |
- |
1,669,649 |
| 2026-02-09 |
Vaishnaw Akshay |
President of R&d |
RSU Award |
47,021 |
- |
- |
642,788 |
| 2026-02-09 |
Marantz Jing L. |
Chief Medical Officer |
RSU Award |
34,482 |
- |
- |
130,169 |
| 2026-02-09 |
Ho Junlin |
General Counsel |
RSU Award |
36,572 |
- |
- |
251,125 |
| 2026-02-09 |
Parlavecchio Caryn |
Chief Human Resources Officer |
RSU Award |
29,258 |
- |
- |
178,122 |
| 2026-02-09 |
Qatanani Mo |
Chief Scientific Officer |
RSU Award |
29,258 |
- |
- |
114,918 |
| 2026-02-09 |
Woods Keith |
Chief Operating Officer |
RSU Award |
47,021 |
- |
- |
630,275 |
| 2026-01-22 |
Qatanani Mo |
Chief Scientific Officer |
Informative Sell |
12,779 |
$46.85 |
$598.75K |
85,660 |
| 2026-01-16 |
Marantz Jing L. |
Chief Medical Officer |
Informative Sell |
5,798 |
$44.48 |
$257.88K |
95,687 |
| 2026-01-16 |
Ho Junlin |
General Counsel |
Informative Sell |
8,016 |
$44.48 |
$356.53K |
214,553 |
| 2026-01-16 |
Parlavecchio Caryn |
Chro |
Informative Sell |
6,600 |
$44.48 |
$293.55K |
148,864 |
| 2026-01-16 |
Qatanani Mo |
Chief Scientific Officer |
Informative Sell |
8,406 |
$44.48 |
$373.88K |
100,558 |
| 2026-01-14 |
Qatanani Mo |
Chief Scientific Officer |
Option Exercise (Sell) |
1,407 |
$18.08 |
$25.44K |
- |
| 2026-01-13 |
Sinha Vikas |
Chief Financial Officer |
Informative Sell |
16,755 |
$42.70 |
$715.44K |
583,245 |
| 2026-01-13 |
Hallal David |
Chief Executive Officer |
Informative Sell |
57,450 |
$42.70 |
$2.45M |
1,541,645 |
| 2026-01-13 |
Vaishnaw Akshay |
President of R&d |
Informative Sell |
20,438 |
$42.70 |
$872.7K |
595,767 |
| 2026-01-13 |
Woods Keith |
Chief Operating Officer |
Informative Sell |
16,746 |
$42.70 |
$715.05K |
583,254 |
| 2025-12-16 |
Peng Katie |
Director |
Informative Sell |
280 |
$44.63 |
$12.5K |
32,908 |
| 2025-12-12 |
Akkaraju Srinivas |
Director |
Option Exercise (ITM) |
1,064,804 |
$7.35 |
$7.83M |
- |
| 2025-12-11 |
Invus Global Management, Llc |
10 Percent Owner |
Option Exercise (ITM) |
1,575,008 |
$7.35 |
$11.58M |
- |
| 2025-12-04 |
Qatanani Mo |
Chief Scientific Officer |
Option Exercise (Sell) |
5,607 |
$4.86 |
$27.25K |
- |
| 2025-10-08 |
Hallal David |
Chief Executive Officer |
Gift (Given) |
205,000 |
- |
- |
1,599,095 |
| 2025-10-07 |
Akkaraju Srinivas |
Director |
Informative Buy |
12,796 |
$39.31 |
$503.01K |
513,235 |
| 2025-10-06 |
Akkaraju Srinivas |
Director |
Informative Buy |
18,414 |
$37.89 |
$697.71K |
405,828 |
| 2025-10-03 |
Akkaraju Srinivas |
Director |
Informative Buy |
11,011 |
$35.61 |
$392.1K |
11,011 |
| 2025-09-22 |
Qatanani Mo |
Chief Scientific Officer |
Informative Sell |
3,353 |
$30.67 |
$102.85K |
108,964 |
| 2025-09-16 |
Qatanani Mo |
Chief Scientific Officer |
Informative Sell |
3,178 |
$33.52 |
$106.53K |
112,317 |
| 2025-09-16 |
Peng Katie |
Director |
Informative Sell |
76 |
$33.20 |
$2.52K |
33,914 |
| 2025-08-18 |
Parlavecchio Caryn |
Chro |
Informative Sell |
2,178 |
$31.17 |
$67.88K |
155,464 |
| 2025-07-16 |
Flier Jeffrey S. |
Director |
Informative Sell |
11,136 |
$40.02 |
$445.69K |
- |
| 2025-07-08 |
Qatanani Mo |
Chief Scientific Officer |
Informative Sell |
24,066 |
$34.44 |
$828.9K |
115,495 |
| 2025-06-23 |
Flier Jeffrey S. |
Director |
Option Exercise (Sell) |
20,316 |
$21.62 |
$439.23K |
- |
| 2025-06-16 |
Ho Junlin |
General Counsel |
Informative Sell |
7,442 |
$32.00 |
$238.15K |
222,569 |
| 2025-06-16 |
Parlavecchio Caryn |
Chro |
Informative Sell |
6,186 |
$32.00 |
$197.96K |
157,642 |
| 2025-06-16 |
Qatanani Mo |
Chief Scientific Officer |
Informative Sell |
3,668 |
$32.00 |
$117.38K |
139,561 |
| 2025-06-16 |
Peng Katie |
Director |
Informative Sell |
54 |
$32.53 |
$1.76K |
34,920 |
| 2025-06-09 |
Ho Junlin |
General Counsel |
RSU Award |
11,429 |
$34.07 |
$389.39K |
11,429 |
| 2025-05-29 |
Gilman Michael |
Director |
Informative Sell |
2,745 |
$29.83 |
$81.9K |
55,216 |
| 2025-05-29 |
Vaishnaw Akshay |
President of R&d |
Informative Sell |
1,620 |
$30.01 |
$48.61K |
616,205 |
| 2025-05-29 |
Burow Kristina |
Director |
Informative Sell |
4,400 |
$29.83 |
$131.27K |
21,071 |
| 2025-05-29 |
Brudnick Richard |
Director |
Informative Sell |
1,400 |
$30.00 |
$42K |
15,057 |
| 2025-05-29 |
Flier Jeffrey S. |
Director |
Informative Sell |
4,975 |
$29.84 |
$148.43K |
24,070 |
| 2025-05-29 |
Reed Joshua |
Director |
Informative Sell |
500 |
$30.04 |
$15.02K |
15,732 |
| 2025-05-22 |
Akkaraju Srinivas |
Director |
RSU Award |
9,206 |
$30.46 |
$280.41K |
9,206 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
